PPF ("PMG Partners Funds") - PMG Global Biotech Fund I

Dati di base

ISIN LU0426487442
Numero di valore 10173746
Bloomberg Global ID BBG000LZWTW4
Nome del fondo PPF ("PMG Partners Funds") - PMG Global Biotech Fund I
Offerente del fondo PMG Investment Solutions AG Zug, Schweiz
Telefono: +41 44 215 28 38
E-Mail: pmg@pmg.swiss
Web: https://www.pmg.swiss
Offerente del fondo PMG Investment Solutions AG
Rappresentante in Svizzera PMG Investment Solutions AG
Zug
Telefono: +41 44 215 28 38
Distributore(i) PMG Investment Solutions AG
Zug
Telefono: +41 44 215 28 38
Asset class Fondi azionari
EFC Categoria
Classe di quote Accumulation
Paese di domicilio Lussemburgo
Condizioni all-unknown-emissione Commissione di emissione a favore della direzione del fondo e/o del distributore (può variare per stesso fondo a seconda del canale di distribuzione)
Condizioni al riscatto Nessuna commissione di riscatto e/o altre commissioni a favore del fondo (riscatto al valore d’inventario)
Strategia d'investimenti *** The objective of the investment policy of the Subfund is to achieve the highest possible long-term capital growth in US dollars by taking advantage of the opportunities offered by biotech and pharmaceutical shares on the global stock markets. This involves investing in listed shares of companies that specialise in the identification, development and production of innovative chemical products for the healthcare sector. To achieve the investment objectives, the subfund will primarily invest in equities and, in part, in futures and exchange-traded options. The country-specific focus of the Fund is on the United States, Europe and the Asia region. This focus also includes investments in emerging markets in Europe and Asia. Investments are made in securities irrespective of their market capitalisation (small cap, mid cap, large cap). Up to 10% of the assets of the subfund may also be invested in China Connect Securities via the Stock Connect Programme.
Particolarità

Prezzi del fondo

Prezzo attuale * 88.09 USD 14.11.2024
Prezzo precedente * 90.18 USD 13.11.2024
Max 52 settimani * 95.45 USD 21.08.2024
Min 52 settimani * 76.96 USD 16.11.2023
NAV * 88.09 USD 14.11.2024
Issue Price *
Redemption Price *
Closing Price *
Prezzo minimo indicativo
Attivo del fondo *** 17'164'238
Attivo della classe *** 12'350'811
Trading Information SIX

Performance

Performance YTD +0.66% 29.12.2023
14.11.2024
Performance YTD (in CHF) +6.49% 29.12.2023
14.11.2024
1 mese -3.28% 14.10.2024
14.11.2024
3 mesi -3.47% 14.08.2024
14.11.2024
6 mesi +3.26% 14.05.2024
14.11.2024
1 anno +13.39% 14.11.2023
14.11.2024
2 anni -9.17% 14.11.2022
14.11.2024
3 anni -31.20% 15.11.2021
14.11.2024
5 anni -11.87% 14.11.2019
14.11.2024

Dati fiscali

Quota di partecipazione al capitale in %
Utile totale del fondo in %
Quota immobiliare in %
ADDI
ADDI Date

10 posizioni principali ***

SIGA Technologies Inc 6.71%
Regeneron Pharmaceuticals Inc 5.23%
Amgen Inc 5.06%
Moderna Inc 4.84%
Vertex Pharmaceuticals Inc 3.65%
Biogen Inc 3.60%
Illumina Inc 3.60%
Chimerix Inc 3.51%
BioNTech SE ADR 3.31%
Seagen Inc Ordinary Shares 2.86%
Ultimo aggiornamento dei dati 31.08.2022

Costi / Rischi

TER 2.12%
Data TER 30.06.2024
Performance Fee *** 20.00%
PTR
Max. Management Fee *** 1.20%
Ongoing Charges *** 1.70%
SRRI ***
Data SRRI *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price commissioni escluse, per fondi quotati in borsa NAV o quotazione di chiusura
** La calculazione del utile intermedio era fatto via § 9 Satz 2 InvStG
*** Sorgente dati: Morningstar (I dati si basano sulla posizione lunga riscalata delle partecipazioni)